The Food and Drug Administration (FDA) Office of Combination Products (OCP) will host a webinar on the final rule “Postmarketing Safety Reporting for Combination Products” on Friday, February 3, 2017, from 9am to 10am EST. OCP’s Associate Director for Policy, John Barlow Weiner, Esq., will present the rule, address agency plans and expectations related to the rule, and respond to questions submitted during the presentation.
No pre-registration is required. Those interested in attending the live webinar may do so by visiting this link at 9am EST on Friday, February 3:
For those unable to attend at the scheduled time, the webinar will be recorded and posted on the OCP website.